Mustafa Nurulhuda相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies

CD38单克隆抗体在血液系统恶性肿瘤中抗癌疗效的分子决定因素

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom12091261

Mustafa, Nurulhuda; Azaman, Muhamad Irfan; Ng, Giselle G K; Chng, Wee Joo

单克隆抗体

发表日期：2022

文献求助收藏

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma

Epstein-Barr病毒阳性自然杀伤细胞和T细胞淋巴瘤对达雷妥尤单抗治疗反应的决定因素

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2020-002123

Mustafa, Nurulhuda; Nee, Adina Huey Fang; Chooi, Jing Yuan; Toh, Sabrina Hui Min; Chung, Tae-Hoon; Selvarajan, Viknesvaran; Fan, Shuangyi; Ng, Siok Bian; Poon, Michelle; Chan, Esther; Lee, Joanne; Chee, Yen Lin; Jeyasekharan, Anand D; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo

自然杀伤细胞

细胞生物学

免疫/内分泌

发表日期：2021

文献求助收藏

Customer churn prediction for telecommunication industry: A Malaysian Case Study

电信行业客户流失预测：马来西亚案例研究

期刊:F1000Research

doi:10.12688/f1000research.73597.1

Mustafa, Nurulhuda; Sook Ling, Lew; Abdul Razak, Siti Fatimah

发表日期：2021

文献求助收藏

VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of Bim

VS-5584 通过上调 II 类肿瘤抑制基因 RARRES3 和激活 Bim 发挥强效抗骨髓瘤活性。

期刊:Oncotarget

doi:10.18632/oncotarget.21988

Mustafa, Nurulhuda; Ting Lee, Jeannie Xue; Adina Nee, Huey Fang; Bi, Chonglei; Chung, Tae-Hoon; Hart, Stefan; Chng, Wee Joo

发表日期：2017

文献求助收藏

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-ÎºB regulated gene products in multiple myeloma xenograft mouse model.

百里醌通过消除多发性骨髓瘤异种移植小鼠模型中 NF-κB 调控的基因产物，克服化疗耐药性并增强硼替佐米的抗癌作用

期刊:Oncotarget

doi:10.18632/oncotarget.1596

Siveen Kodappully Sivaraman, Mustafa Nurulhuda, Li Feng, Kannaiyan Radhamani, Ahn Kwang Seok, Kumar Alan Prem, Chng Wee-Joo, Sethi Gautam

发表日期：2014

文献求助收藏